Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector
Reexamination Certificate
2005-11-15
2005-11-15
Nolan, Patrick J. (Department: 1644)
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
C530S328000, C530S327000, C514S014800, C514S015800, C435S007100, C435S029000
Reexamination Certificate
active
06964766
ABSTRACT:
The invention relates to the use of novel peptides in a peptide induced tolerance therapy to prevent autoimmune disorders and in particular their use in treatment of chronic destruction of articular cartilage. The invention furtermore embraces pharmaceutical compositions comprising said peptides and a diagnostic method for the detection of autoreactive T cells in a test sample.
REFERENCES:
patent: 0 805 206 (1997-11-01), None
patent: WO 96 13517 (1996-05-01), None
patent: WO 97 40068 (1997-10-01), None
patent: WO 98 06859 (1998-02-01), None
Hu et al. JBC vol 271, pp. 19415-19420, 1996.
Wendling et al. J of Immunology. vol: 164: 2711-2717, 2000.
Boots Anna Maria Helena
Verheijden Gijsbertus Franciscus Maria
Akzo Nobel N.V.
Blackstone William M.
Nolan Patrick J.
Ramey William P.
LandOfFree
Peptides for use in immunotherapy of autoimmune diseases does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Peptides for use in immunotherapy of autoimmune diseases, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peptides for use in immunotherapy of autoimmune diseases will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3481448